Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis. | Arthritis Res Ther | 2024 | 38254179 | PubTator, text mining | PubMed |
| Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. | Theranostics | 2024 | 38169544 | PubTator, text mining | PubMed |
| Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma. | Transl Oncol | 2024 | 38141377 | PubTator, text mining | PubMed |
| Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis. | Brain | 2024 | 38038362 | PubTator, text mining | PubMed |
| Interplay between the plasma membrane and cell-cell adhesion maintains epithelial identity for correct polarised cell divisions. | J Cell Sci | 2024 | 37888135 | PubTator, text mining | PubMed |
| Modeling the Annexin A1-S100A11 heterotetramer: a molecular dynamics investigation of structure and correlated motion. | J Biomol Struct Dyn | 2024 | 37194290 | PubTator, text mining | PubMed |
| Identification of a novel, MSC-induced macrophage subtype via single-cell sequencing: implications for intervertebral disc degeneration therapy. | Front Cell Dev Biol | 2023 | 38274272 | PubTator, text mining | PubMed |
| Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia. | Front Oncol | 2023 | 38239636 | PubTator, text mining | PubMed |
| ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma. | Front Immunol | 2023 | 38223508 | PubTator, text mining | PubMed |
| Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture. | Front Immunol | 2023 | 38162650 | PubTator, text mining | PubMed |
| Salivary Extracellular Vesicles: Biomarkers and Beyond in Human Diseases. | Int J Mol Sci | 2023 | 38139157 | PubTator, text mining | PubMed |
| Anti-Osteoarthritis Mechanism of the Nrf2 Signaling Pathway. | Biomedicines | 2023 | 38137397 | PubTator, text mining | PubMed |
| Exploring the prognostic value of S100A11 and its association with immune infiltration in breast cancer. | Sci Rep | 2023 | 38129538 | PubTator, text mining | PubMed |
| Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma. | Front Immunol | 2023 | 38116005 | PubTator, text mining | PubMed |
| Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | Cell Mol Life Sci | 2023 | 38092984 | PubTator, text mining | PubMed |
| Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. | J Extracell Vesicles | 2023 | 38082559 | PubTator, text mining | PubMed |
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas. | Front Pharmacol | 2023 | 38053842 | PubTator, text mining | PubMed |
| Identification of a Novel CD8+ T cell exhaustion-related gene signature for predicting survival in hepatocellular carcinoma. | BMC Cancer | 2023 | 38049741 | PubTator, text mining | PubMed |
| Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2023 | 38034399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers?page=7